For the last seven years, I’ve managed clinical protocols at a medical aesthetics practice. I’ve personally made—and documented—11 significant mistakes related to laser, light, and radiofrequency treatments. Together, those mistakes cost roughly $46,000 in refunds, overtime, and product waste. Now I maintain the checklist that keeps our team from repeating them.
This is not an official Solta Medical piece. I don't work for the company. I just have a strong opinion: most clinics answer “how to maintain results after Thermage” with a sales pitch instead of an actual protocol. That’s backwards.
The surface question: “How do I maintain results after Thermage?”
I hear this exact phrase from patients around week 10 after their Thermage treatment. The skin looks good. They want to know how to keep it. And for my first two years, I gave a classic answer: “Book one session per year.”
Wrong.
Not because annual Thermage is always wrong—or because the device is bad. The problem is that skin doesn’t work on a calendar schedule. Thermage uses radiofrequency energy to heat the dermis. That heat causes immediate collagen contraction and, over the following months, triggers new collagen formation. The result is a biologic response, not a filing deadline.
According to FDA 510(k) summaries, Thermage is cleared for non-invasive treatment of wrinkles and skin laxity. That’s regulatory language. It doesn’t tell you when a specific patient should be re-treated. The optimal interval depends on age, skin quality, hormonal status, and whether the patient is doing anything that undermines collagen production.
Honestly, I’m not sure why some patients show dramatic results in six weeks while others need four months. My best guess is baseline collagen condition and provider skill. That uncertainty is uncomfortable, but it’s better than pretending every patient follows the same curve.
The deeper problem: Treating Thermage maintenance like an IPL photofacial
Here’s the thing: once a clinic starts offering “skin rejuvenation,” everything starts to look like the same treatment. It isn’t.
Search “photofacial IPL treatment” and you’ll see thousands of deals. IPL—intense pulsed light—uses broad-spectrum light, not a laser. It’s excellent for broken capillaries, flushing, and some superficial pigmentation. But it doesn’t behave like Thermage. It doesn’t deliver the same kind of controlled depth, and it won’t maintain a radiofrequency collagen response. If someone needs Thermage maintenance and you hand them an IPL, they’ll get a nice glow and a false sense of progress.
Then there’s ablative laser resurfacing. I learned this lesson the expensive way. Ablative laser resurfacing vaporizes the epidermis, stimulates significant dermal remodeling, and produces real—sometimes dramatic—results. But it also comes with real downtime: crusting, redness, infection risk, and pigment changes. Non-ablative fractional lasers, like Fraxel, create microscopic treatment zones while leaving surrounding tissue intact. They’re a different conversation from IPL, and a different conversation from full ablative resurfacing.
I still read Solta Medical news because protocol guidance changes more often than people assume. Solta Medical Corporation publishes educational materials for Thermage, Fraxel, and Clear + Brilliant. The conservative message in those materials is almost always “choose the right patient, use the right setting.” That’s not a marketing slogan. That’s operational discipline.
The actual cost of getting the protocol wrong
In 2021, I launched a package called “Resurface and Maintain.” It bundled an IPL photofacial with a Thermage touch-up. The goal was to increase average ticket. The result was a masterclass in poor patient selection.
A 42-year-old woman with melasma bought the package. After her first IPL, her pigmentation got darker. We stopped treatment, referred her to a dermatologist, and refunded $2,850. Her skin eventually recovered, but she never returned.
Then there was a 55-year-old man with significant jowling. He had consulted us about a surgical neck lift. We talked him into Thermage instead. Five months later, his photos showed maybe a 5% improvement. He wanted to know why we didn’t recommend surgery, and he was right to ask. The device didn’t fail. The screening did. That refund cost $2,000 plus 14 hours of clinical time.
Those two cases alone were about $4,850. Add cancelled bookings, staff overtime, and the silent damage from word-of-mouth, and the true number was closer to $9,400 for one quarter. Maybe I’m conflating two different years; I’d have to check our audit spreadsheet. The exact figure doesn’t matter. The pattern does.
The upside of adding aggressive fractional laser work was a higher average ticket—around $3,500 per case. The risk was treating someone with a red flag in their history, like recent isotretinoin use, and causing a serious complication. I kept asking myself: is $3,500 worth potentially damaging someone’s face? That question led to our current pre-screen checklist.
What changed: maintenance as an evolving decision
Five years ago, waiting until a patient asked about maintenance was normal. Today that feels negligent. The fundamentals haven’t changed—collagen still needs time, and no device replaces honest consultation—but execution has transformed. We now use standardized photos, objective improvement scales, and a written plan before any touch-up is sold.
To answer the original question directly: how to maintain results after Thermage is not a single treatment code. It’s a protocol built around the patient’s individual response:
- Assess the result at 3 months and photograph at 6 months.
- Plan retreatment at 12 to 18 months, not on a blanket “annual” schedule.
- If texture and tone need help, consider Clear + Brilliant or non-ablative fractional laser before jumping to photofacial IPL treatment.
- If a patient needs significant correction, say the words “ablative laser resurfacing” or “surgical consult” instead of hiding it behind maintenance language.
- No guarantee of zero side effects. No “forever” promises.
Photofacial IPL treatment still has a place in our clinic. So does Fraxel. And for the rare, carefully chosen patient, true ablative laser resurfacing gives results that fractional lasers simply can’t match. The difference is intent: a photofacial is not a maintenance protocol for a radiofrequency treatment, and a tiny annual laser is not a substitute for a resurfacing procedure.
Even after making these changes, I second-guessed myself. What if booking fewer annual Thermage sessions cut into revenue? What if patients expected to hear “come back next year” and felt abandoned when we told them to wait? The first six months, we made about the same money—but we made it by selling more targeted Fraxel sessions and fewer inappropriate packages. I finally relaxed when a patient said, “You’re the only clinic that didn’t try to sell me something.”
That’s the real lesson. The device is not the product. The clinical decision-making is. And if you’re Googling “solta medical news” because you want to know which machine to buy, you might be looking at the wrong variable.
Buying a Solta Medical system, or any system, doesn’t solve protocol mistakes. A good checklist doesn’t make the device better—it makes you better at knowing when not to use it. That’s the part no press release will tell you.
